Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / People / Joshua J. Ofman
Person

Joshua J. Ofman

Tracked across 2 events · 198 articles · First seen Jun 09, 2026 · Last active Aug 10, 2026

Sentiment
0
Attention
4
Events
2
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (2)
4 -70
Regulatory
GRAIL Securities Fraud Class Action
Impact: Joshua J. Ofman, President of Illumina — Holy Grail, is named as an individual defendant for his role in allegedly misleading investors about the NHS-Galleri trial.
Jun 09, 2026 · 192 articles
4 70
Regulatory
FDA Panel to Review GRAIL Galleri PMA
Illumina — Holy Grail, Inc. announced that the U.S. United States — Food and Drug Administration's Molecular and Clinical Genetics Panel of the Medical Devices Advisory Committee will meet on September 23, 2026, to review…
Impact: Joshua J. Ofman, CEO of Illumina — Holy Grail, is the public spokesperson and leader driving the regulatory submission and strategic direction.
Aug 07, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Joshua J. Ofman live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.